Secondary hematological malignancies after breast cancer chemotherapy

Leukemia and Lymphoma

Volumn 46, Issue 8, 2005, Pages 1183-1188

  Park, Myung Joon ^a   Park, Yeon Hee ^a   Ahn, Heui June ^a   Choi, Won ^a   Paik, Kwang Hyun ^a   Kim, Jung Min ^a   Chang, Yoon Hwan ^a   Ryoo, Baek Yeol ^a   Yang, Sung Hyun ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

AML; Breast cancer; Lymphoma; MDS; Secondary hematological malignancies

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MITOXANTRONE; PACLITAXEL; PREDNISOLONE; TAMOXIFEN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; B CELL LYMPHOMA; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CLINICAL ARTICLE; DEATH; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MANTLE CELL LYMPHOMA; MASTECTOMY; MYELODYSPLASTIC SYNDROME; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; SECOND CANCER;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; TREATMENT OUTCOME;

EID: 23144438945     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500125705     Document Type: Article

References (20)

1. Weldon CB, Jeffe BM, Kahn M.J. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol 2002;9:738-744.
2. Curtis RE, Boice JD, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-1751.
3. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000; 18:2406-2412.
4. Roy ES, John B, Arthur D et al. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the national surgical adjuvant breast and bowel project experience. J Clin Oncol 2002;21:1195-1204.
5. Chaplain G, Milan C, Sgro C et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000;18:2836-2842.
6. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D et al. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992;10:1444-1451.
7. Pedersen-Bjergaard J, Philip P, Larsen SO et al. Therapy-related myelodysplasia and acute leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993;7:1975-1986.
8. Saso R, Kulkarni S, Mitchell P et al. Secondary myelodysplastic syndrome/acute myeloid leukemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 2000;83:91-94.
9. Pedersen-Bjergaard J, Pedersen M, Roulston D et al. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995;86:3542-3552.
10. Kroger N, Damon L, Zander AR et al. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone Marrow Transplantation 2003;32:1153-1157.
11. Bernard-Marty C, Mano M, Paesmans C et al. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 2003;14:693-698.
12. Roussel M. Non-Hodgkin's lymphoma in women with breast cancer: a retrospective study of 46 patients. J Clin Oncol 2004;22(14S):6670.
13. Fisher B, Rockette H, Fisher ER et al. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985;12:1640-1658.
14. Haas JF, Kittelmann B, Melmer WH et al. Risk of leukemia in ovarian tumor and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 1987;55:213-218.
15. Curtis RE, Boice JD, Moloney WC et al. Leukemia following chemotherapy for breast cancer. Cancer Res 1990;50:2741-2746.
16. Valagussa P, Moliterni A, Terenziani M et al. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 1996;5:803-808.
17. Diamandidou E, Buzdar AU, Smith TL et al. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 1996;14:2722-2730.
18. Laughlin MJ, McGaughey DS, Crews JR et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 1998;16:1008-1012.
19. Linassier C, Barin C, Calais G et al. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 2000;11:1289-1294.
20. Kroger N, Zander AR, Martinelli G et al. European Group for Blood and Marrow Transplantation. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Ann Oncol 2003;14:554-558.